Drug intelligence / Profile preview

Jiechangyan

Development stage
Preclinical
Lead developer
Jinan Kangzhong Pharmaceutical Technology Development
Modality
Small Molecules
Administration
Oral
01

Overview

Jiechangyan is a Traditional Chinese Medicine (TCM) preparation developed by Jinan Kangzhong Pharmaceutical Technology Development Co., Ltd. specifically for the treatment of ulcerative colitis. As a multi-component herbal formulation, it is designed to address the complex pathophysiology of inflammatory bowel disease through a multi-target approach. The drug functions by inhibiting the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β), while also modulating the NF-kappaB signaling pathway. Additionally, Jiechangyan is thought to promote the repair of the intestinal mucosal barrier and regulate the balance of the gut microbiota. In clinical practice within China, such formulations are used to induce and maintain remission in patients with active ulcerative colitis, particularly those with the 'damp-heat' internal accumulation pattern according to TCM diagnostics.

Brand names
Jiechangyan
Other names
Jiechangyan WanJiechangyan CapsulesColitis Pills结肠炎
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)NF-κB

Beyond the preview

Go deeper on Jiechangyan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiechangyan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call